Glenmark Life Sciences sets Indian IPO rolling

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

Glenmark Life Sciences sets Indian IPO rolling

Jonathan Breen
April 19, 2021 09:15 am
Pharma_drugs_adobe_575x375.jpg
siro46 - stock.adobe.com

India’s Glenmark Life Sciences, a pharmaceutical ingredients maker, has filed draft paperwork for an IPO of new and existing shares.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsHealth and BiotechEquityBank of AmericaIndiaAsiaSouth AsiaAsia PacificEmerging MarketsSRIState Bank of India SBIGoldman Sachs
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article